DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 234 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,292,715 | -72.1% | 87,523 | -80.3% | 0.00% | -70.0% |
| Q3 2022 | $4,636,000 | -50.6% | 444,132 | -48.7% | 0.01% | -44.4% |
| Q1 2022 | $9,389,000 | -21.7% | 866,332 | +1.7% | 0.02% | -18.2% |
| Q4 2021 | $11,985,000 | -87.8% | 851,895 | -83.4% | 0.02% | -94.6% |
| Q3 2021 | $98,295,000 | +2785.1% | 5,116,856 | +1376.4% | 0.41% | +2450.0% |
| Q1 2021 | $3,407,000 | +1319.6% | 346,586 | +953.5% | 0.02% | +1500.0% |
| Q1 2019 | $240,000 | +421.7% | 32,898 | +549.9% | 0.00% | – |
| Q4 2018 | $46,000 | -97.6% | 5,062 | -96.8% | 0.00% | -100.0% |
| Q3 2018 | $1,948,000 | +109.7% | 157,172 | +225.5% | 0.01% | -11.1% |
| Q1 2016 | $929,000 | +288.7% | 48,285 | +396.4% | 0.01% | +200.0% |
| Q3 2015 | $239,000 | -80.5% | 9,727 | -81.4% | 0.00% | -81.2% |
| Q2 2015 | $1,227,000 | – | 52,377 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |